2000Journal of Jinan UniversityRequires access

Bcl-2 expression in eutopic endometrium and uterine adenomyotic tissue

Haiyan Jin

Open publisher page 0 citations

Abstract

Aim: To investigate Bcl-2 expression in human eutopic endometrium and adenomyotic tissues during the menstrual cycle and discuss the cause of different Bcl-2 expression between uterine adenomyosis and endometriosis. Methods: Bcl-2 expression was studied by an immunohistochemical LSAB method in 20 samples of eutopic and ectopic endometrium in adenomyosis. Results: The expression of Bcl-2 in eutopic endometrial glandular cells was observed at prolifertive through early secretory phases and peaked at the end of proliferative phase, but not at mid and late secretory phases. The expression of Bcl-2 in ectopic glandular cells of adenomyosis showed apparent cyclic changes during the menstrual cycle. Bcl-2 was strongly expressed during the proliferative phase, but weakly expressed during the secretory phase. Conclusion: The cyclic changes of Bcl-2 expression in adenomyotic tissues implied a difference in the pathogenesis or condition of the cells between adenomyosis and endometriosis.[

About this research paper

What this paper is about

Aim: To investigate Bcl-2 expression in human eutopic endometrium and adenomyotic tissues during the menstrual cycle and discuss the cause of different Bcl-2 expression between uterine adenomyosis and endometriosis. Methods: Bcl-2 expression was studied by an immunohistochemical LSAB method in 20 samples of eutopic and ectopic endometrium in adenomyosis. Results: The expression of Bcl-2 in eutopic endometrial glandular cells was observed at prolifertive through early secretory phases and peaked at the end of proliferative phase, but not at mid and late secretory phases. The expression of Bcl-2 in ectopic glandular cells of adenomyosis showed apparent cyclic changes during the menstrual cycle. Bcl-2 was strongly expressed during the proliferative phase, but weakly expressed during the secretory phase. Conclusion: The cyclic changes of Bcl-2 expression in adenomyotic tissues implied a difference in the pathogenesis or condition of the cells between adenomyosis and endometriosis.[

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Aim: To investigate Bcl-2 expression in human eutopic endometrium and adenomyotic tissues during the menstrual cycle and discuss the cause of different Bcl-2 expression between uterine adenomyosis and endometriosis. Methods: Bcl-2 expression was studied by an immunohistochemical LSAB method in 20 samples of eutopic and ectopic endometrium in adenomyosis. Results: The expression of Bcl-2 in eutopic endometrial glandular cells was observed at prolifertive through early secretory phases and peaked at the end of proliferative phase, but not at mid and late secretory phases. The expression of Bcl-2 in ectopic glandular cells of adenomyosis showed apparent cyclic changes during the menstrual cycle. Bcl-2 was strongly expressed during the proliferative phase, but weakly expressed during the secretory phase. Conclusion: The cyclic changes of Bcl-2 expression in adenomyotic tissues implied a difference in the pathogenesis or condition of the cells between adenomyosis and endometriosis.[

Key concepts: Adenomyosis, Endometriosis, Immunohistochemistry, Endometrium, Menstrual cycle, Pathogenesis, Follicular phase, Uterus

Related papers

Back to paper searchBrowse research topicsOriginal source
Bcl-2 expression in eutopic endometrium and uterine adenomyotic tissue — Research Paper | ScholarLens